Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Milinkovic

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1Jordi Blanch, Araceli Rousaud, Esteban Martinez, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2008
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumptionAgathe León, Esteban Martinez, Ana Milinkovic, et al.
AIDS (London, England)|September 7, 2006
Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutationsJose Luis Blanco, Alejandra Biglia, Elisa De Lazzari, et al.
Virology Journal|February 10, 2025
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)Collins Iwuji, Laura Waters, Ana Milinkovic, et al.
International Journal of STD & AIDS|November 16, 2023
Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL)Charlotte O'Halloran, Yvonne Gilleece, Suki Leung, et al.
HIV Medicine|May 6, 2026
Preference for different PrEP formulations: A cross-sectional study in a PrEP cohort in SpainAlfredo Soler-Carracedo, Allison R Webel, Luis Ramos-Ruperto, et al.
HIV Research & Clinical Practice|September 8, 2024
A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnTGary Whitlock, Sarah Fidler, Amanda Clarke, et al.
Antiviral Therapy|March 26, 2004
Mitochondrial effects of antiretroviral therapies in asymptomatic patientsSònia López, Oscar Miró, Esteban Martínez, et al.
AIDS (London, England)|October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIVJames E Burns, Oliver T Stirrup, David Dunn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2009
Genetic and functional mitochondrial assessment of HIV-infected patients developing HAART-related hyperlactatemiaGlòria Garrabou, Constanza Morén, Jose Miguel Gallego-Escuredo, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1Jordi Blanch, Araceli Rousaud, Esteban Martinez, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2008
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumptionAgathe León, Esteban Martinez, Ana Milinkovic, et al.
AIDS (London, England)|September 7, 2006
Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutationsJose Luis Blanco, Alejandra Biglia, Elisa De Lazzari, et al.
Virology Journal|February 10, 2025
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)Collins Iwuji, Laura Waters, Ana Milinkovic, et al.
International Journal of STD & AIDS|November 16, 2023
Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL)Charlotte O'Halloran, Yvonne Gilleece, Suki Leung, et al.
HIV Medicine|May 6, 2026
Preference for different PrEP formulations: A cross-sectional study in a PrEP cohort in SpainAlfredo Soler-Carracedo, Allison R Webel, Luis Ramos-Ruperto, et al.
HIV Research & Clinical Practice|September 8, 2024
A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnTGary Whitlock, Sarah Fidler, Amanda Clarke, et al.
Antiviral Therapy|March 26, 2004
Mitochondrial effects of antiretroviral therapies in asymptomatic patientsSònia López, Oscar Miró, Esteban Martínez, et al.
AIDS (London, England)|October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIVJames E Burns, Oliver T Stirrup, David Dunn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2009
Genetic and functional mitochondrial assessment of HIV-infected patients developing HAART-related hyperlactatemiaGlòria Garrabou, Constanza Morén, Jose Miguel Gallego-Escuredo, et al.
Pageof 8